Hiroshi Tsuda

5.4k total citations
150 papers, 4.1k citations indexed

About

Hiroshi Tsuda is a scholar working on Rheumatology, Immunology and Reproductive Medicine. According to data from OpenAlex, Hiroshi Tsuda has authored 150 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Rheumatology, 30 papers in Immunology and 28 papers in Reproductive Medicine. Recurrent topics in Hiroshi Tsuda's work include Systemic Lupus Erythematosus Research (29 papers), Endometrial and Cervical Cancer Treatments (22 papers) and Ovarian cancer diagnosis and treatment (17 papers). Hiroshi Tsuda is often cited by papers focused on Systemic Lupus Erythematosus Research (29 papers), Endometrial and Cervical Cancer Treatments (22 papers) and Ovarian cancer diagnosis and treatment (17 papers). Hiroshi Tsuda collaborates with scholars based in Japan, United States and Australia. Hiroshi Tsuda's co-authors include Shigeru Saito, Hugo J. Bellen, TOSHIHIKO MICHIMATA, Masatoshi Sakai, Chao Tong, Kyoko Tanebe, Yasushi Sasaki, Hiroshi Hashimoto, Takeshi Inoue and Yoshinari Takasaki and has published in prestigious journals such as Cell, Journal of Clinical Oncology and Journal of Neuroscience.

In The Last Decade

Hiroshi Tsuda

145 papers receiving 4.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroshi Tsuda Japan 34 1.3k 1.2k 732 590 541 150 4.1k
Hubert Schorle Germany 45 2.7k 2.1× 4.6k 3.8× 223 0.3× 487 0.8× 360 0.7× 135 8.8k
Reidar Albrechtsen Denmark 44 586 0.5× 2.6k 2.2× 292 0.4× 253 0.4× 238 0.4× 112 6.0k
Kazuo Motoyoshi Japan 33 1.4k 1.1× 1.6k 1.4× 144 0.2× 122 0.2× 197 0.4× 157 4.0k
Anna Starzinski‐Powitz Germany 39 1.7k 1.3× 2.0k 1.7× 1.2k 1.6× 1.7k 2.9× 181 0.3× 98 4.9k
Olavio R. Baricordi Italy 32 2.0k 1.6× 704 0.6× 343 0.5× 590 1.0× 783 1.4× 71 4.1k
Dragoş Crețoiu Romania 40 578 0.5× 2.5k 2.1× 360 0.5× 589 1.0× 338 0.6× 129 5.0k
Roger A. Williamson United States 34 455 0.4× 3.8k 3.2× 226 0.3× 384 0.7× 428 0.8× 96 6.3k
Joel N. H. Stern United States 27 1.5k 1.2× 979 0.8× 112 0.2× 116 0.2× 154 0.3× 65 3.3k
K. Miyazaki Japan 34 627 0.5× 1.3k 1.1× 1.1k 1.5× 1.4k 2.3× 334 0.6× 94 4.2k
Craig A. Harrison Australia 40 611 0.5× 3.1k 2.6× 157 0.2× 591 1.0× 737 1.4× 108 4.6k

Countries citing papers authored by Hiroshi Tsuda

Since Specialization
Citations

This map shows the geographic impact of Hiroshi Tsuda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Tsuda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Tsuda more than expected).

Fields of papers citing papers by Hiroshi Tsuda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroshi Tsuda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Tsuda. The network helps show where Hiroshi Tsuda may publish in the future.

Co-authorship network of co-authors of Hiroshi Tsuda

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshi Tsuda. A scholar is included among the top collaborators of Hiroshi Tsuda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshi Tsuda. Hiroshi Tsuda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kano, Osamu, et al.. (2022). Rasagiline as Adjunct to Levodopa for Treatment of Parkinson’s Disease: A Systematic Review and Meta‐Analysis. Parkinson s Disease. 2022(1). 4216452–4216452. 3 indexed citations
2.
Abe, Yoshiyuki, Naoto Tamura, Joe Matsuoka, et al.. (2016). Predictive factors for mortality in elderly Japanese patients with severe microscopic polyangiitis: A retrospective single-center study. Modern Rheumatology. 27(2). 315–319. 8 indexed citations
3.
Tanosaki, Ryuji, Akihiro Yoshida, Shinichiro Oguni, et al.. (2013). Novel and rapid enumeration method of peripheral blood stem cells using automated hematology analyzer. International Journal of Laboratory Hematology. 36(5). 521–530. 15 indexed citations
4.
Yang, Junzheng, Shu‐Kay Ng, Shubai Liu, et al.. (2012). Characterization of aldehyde dehydrogenase isozymes in ovarian cancer tissues and sphere cultures. BMC Cancer. 12(1). 329–329. 54 indexed citations
5.
Chiyoda, Tatsuyuki, Hiroshi Tsuda, Hideo Tanaka, et al.. (2011). Expression profiles of carcinosarcoma of the uterine corpus—are these similar to carcinoma or sarcoma?. Genes Chromosomes and Cancer. 51(3). 229–239. 37 indexed citations
6.
Yamaji, Ken, Keisuke Oda, Makio Kusaoi, et al.. (2011). Effect of Various Anticoagulant Agents on Large‐Volume Leukocytapheresis Using New Cellsorba CS‐180S Filter. Therapeutic Apheresis and Dialysis. 15(4). 355–359. 1 indexed citations
7.
Isonuma, Hiroshi, et al.. (2009). Causes of death in hospitalized elderly patients. Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics. 46(1). 71–78. 9 indexed citations
8.
Takano, Masashi, Yoshihiro Kikuchi, Tomoko Gotō, et al.. (2009). Identification of potential serum markers for endometrial cancer using protein expression profiling. Journal of Cancer Research and Clinical Oncology. 136(3). 475–481. 20 indexed citations
9.
Yamaji, Ken, Young‐Joon Kim, Hiroshi Tsuda, & Yoshinari Takasaki. (2008). Long‐term Clinical Outcomes of Synchronized Therapy With Plasmapheresis and Intravenous Cyclophosphamide Pulse Therapy in the Treatment of Steroid‐resistant Lupus Nephritis. Therapeutic Apheresis and Dialysis. 12(4). 298–305. 16 indexed citations
10.
Hashiguchi, Yasunori, Hiroshi Tsuda, Christina A. Bandera, et al.. (2006). Comparison of Osteopontin Expression in Endometrioid Endometrial Cancer and Ovarian Endometrioid Cancer. Medical Oncology. 23(2). 205–212. 14 indexed citations
11.
Tsuda, Hiroshi, Michael J. Birrer, Yoichi M. Ito, et al.. (2004). Identification of DNA copy number changes in microdissected serous ovarian cancer tissue using a cDNA microarray platform. Cancer Genetics and Cytogenetics. 155(2). 97–107. 25 indexed citations
12.
Yamaji, Ken, et al.. (2002). Plasma Adsorption in Critical Care. Therapeutic Apheresis. 6(3). 184–188. 19 indexed citations
13.
Hidaka, Takao, Masaki Fujimura, Akitoshi Nakashima, et al.. (2002). Macrophage Colony‐stimulating Factor (M‐CSF) Prevents Infectious Death Induced by Chemotherapy in Mice, While Granulocyte‐CSF Does Not. Japanese Journal of Cancer Research. 93(4). 426–435. 4 indexed citations
14.
15.
Moore, Malcolm A, et al.. (1998). Physical exercise: a pillar for cancer prevention?. European Journal of Cancer Prevention. 7(3). 177–193. 27 indexed citations
16.
Tsuda, Hiroshi, et al.. (1996). Diagnosis of myometrial invasion of endometrial cancer by intrauterine ultrasonography with a high‐frequency probe and fluid contrast augmentation in the uterine cavity: a preliminary study. BJOG An International Journal of Obstetrics & Gynaecology. 103(8). 840–841. 5 indexed citations
17.
Tsuda, Hiroshi, et al.. (1995). Massive fetomaternal hemorrhage. International Journal of Gynecology & Obstetrics. 50(1). 47–49. 11 indexed citations
18.
Tsuda, Hiroshi, et al.. (1994). Abrogation of Suppressor Cells Activity by cis-Diamminedichloroplatinum (CDDP) Treatment Using Therapeutic Doses in Ovarian Cancer Patients. Gynecologic Oncology. 52(2). 218–221. 7 indexed citations
19.
Tsuda, Hiroshi, et al.. (1992). [Plasmapheresis for patients with RA].. PubMed. 50(3). 543–6.
20.
Hashimoto, Hiroshi, et al.. (1983). Digital ulcers/gangrene and immunoglobulin classes/complement fixation of anti-dsDNA in systemic lupus erythematosus patients.. PubMed. 10(5). 727–32. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hubert Schorle Breakdown of academic impact, for papers by Reidar Albrechtsen Breakdown of academic impact, for papers by Kazuo Motoyoshi Breakdown of academic impact, for papers by Anna Starzinski‐Powitz Breakdown of academic impact, for papers by Olavio R. Baricordi Breakdown of academic impact, for papers by Dragoş Crețoiu Breakdown of academic impact, for papers by Roger A. Williamson Breakdown of academic impact, for papers by Joel N. H. Stern Breakdown of academic impact, for papers by K. Miyazaki Breakdown of academic impact, for papers by Craig A. Harrison
Rankless by CCL
2026